The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

DSE:IBNSINA Revenue

The IBN SINA Pharmaceutical Industry had revenue of 3.75B BDT in the quarter ending December 31, 2025, with 18.10% growth. This brings the company's revenue in the last twelve months to 13.42B, up 16.94% year-over-year. In the fiscal year ending June 30, 2025, The IBN SINA Pharmaceutical Industry had annual revenue of 11.88B with 4.51% growth.

• Revenue (ttm): 13.42B
• Revenue Growth: +16.94%
• P/S Ratio: 0.81
• Revenue / Employee: 2.58M
• Employees: 5,200
• Market Cap: 10.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	11.88B	512.67M	4.51%
Jun 30, 2024	11.37B	2.25B	24.61%
Jun 30, 2023	9.13B	645.51M	7.61%
Jun 30, 2022	8.48B	1.10B	14.96%
Jun 30, 2021	7.38B	1.18B	19.13%